Dr. Thomas Adam is currently the Head of Global Quality Assurance for Chemical APIs in the Chemical Development Department of the Pharmaceutical Business Unit at Bayer. He is responsible for the release of chemical APIs for clinical trials, the GMP-quality system, and the QA oversight of the pilot plants and analytical development laboratories.
Thomas holds a PhD in Analytical Chemistry from the University of Mainz in Germany. He has approximately 25 years of industrial experience at Bayer in various QC/QA functions and two years of postdoctoral experience at Novartis in Switzerland. He has been involved in numerous technical (transfer) projects, including the planning and launch of the new GMP kilogram-scale laboratory for highly potent APIs and the establishment of a cleaning concept for the Chemical Development Department.
